These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 17363005)

  • 41. Cytokeratin expression in pilonidal sinus.
    Kurokawa I; Nishijima S; Suzuki K; Kusumoto K; Sensaki H; Shikata N; Tsubura A
    Br J Dermatol; 2002 Mar; 146(3):409-13. PubMed ID: 11952540
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epidermal psoriasiform hyperplasia, an unrecognized sign of folliculitis decalvans: A histological study of 26 patients.
    Matard B; Cavelier-Balloy B; Reygagne P
    J Cutan Pathol; 2017 Apr; 44(4):352-357. PubMed ID: 28067422
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The non-neuronal cholinergic system in immunocompetent cells].
    Li J; Chen HZ
    Sheng Li Ke Xue Jin Zhan; 2005 Jul; 36(3):193-8. PubMed ID: 16270815
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Skin calcium-binding protein: distribution in other tissues.
    Pavlovitch JH; Didierjean L; Rizk M; Balsan S; Saurat JH
    Am J Physiol; 1983 Jan; 244(1):C50-7. PubMed ID: 6401403
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of three hidradenitis suppurativa phenotypes: latent class analysis of a cross-sectional study.
    Canoui-Poitrine F; Le Thuaut A; Revuz JE; Viallette C; Gabison G; Poli F; Pouget F; Wolkenstein P; Bastuji-Garin S
    J Invest Dermatol; 2013 Jun; 133(6):1506-11. PubMed ID: 23235532
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Incidence of hidradenitis suppurativa among tobacco smokers: a population-based retrospective analysis in the U.S.A.
    Garg A; Papagermanos V; Midura M; Strunk A
    Br J Dermatol; 2018 Mar; 178(3):709-714. PubMed ID: 28960235
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity.
    Zouboulis CC; Tzellos T; Kyrgidis A; Jemec GBE; Bechara FG; Giamarellos-Bourboulis EJ; Ingram JR; Kanni T; Karagiannidis I; Martorell A; Matusiak Ł; Pinter A; Prens EP; Presser D; Schneider-Burrus S; von Stebut E; Szepietowski JC; van der Zee HH; Wilden SM; Sabat R;
    Br J Dermatol; 2017 Nov; 177(5):1401-1409. PubMed ID: 28636793
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hurley Staging Refined: A Proposal by the Dutch Hidradenitis Suppurativa Expert Group.
    Horváth B; Janse IC; Blok JL; Driessen RJ; Boer J; Mekkes JR; Prens EP; van der Zee HH
    Acta Derm Venereol; 2017 Mar; 97(3):412-413. PubMed ID: 27535129
    [No Abstract]   [Full Text] [Related]  

  • 49. Hidradenitis suppurativa: Epidemiology and scope of the problem.
    Jemec GB; Kimball AB
    J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S4-7. PubMed ID: 26470614
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hidradenitis suppurativa: Epidemiology, clinical presentation, and pathogenesis.
    Goldburg SR; Strober BE; Payette MJ
    J Am Acad Dermatol; 2020 May; 82(5):1045-1058. PubMed ID: 31604104
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hidradenitis suppurativa: Current and emerging treatments.
    Goldburg SR; Strober BE; Payette MJ
    J Am Acad Dermatol; 2020 May; 82(5):1061-1082. PubMed ID: 31604100
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased prevalence of metabolic syndrome in patients with acne inversa.
    Sabat R; Chanwangpong A; Schneider-Burrus S; Metternich D; Kokolakis G; Kurek A; Philipp S; Uribe D; Wolk K; Sterry W
    PLoS One; 2012; 7(2):e31810. PubMed ID: 22359634
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β.
    van der Zee HH; de Ruiter L; van den Broecke DG; Dik WA; Laman JD; Prens EP
    Br J Dermatol; 2011 Jun; 164(6):1292-8. PubMed ID: 21332464
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial.
    Grant A; Gonzalez T; Montgomery MO; Cardenas V; Kerdel FA
    J Am Acad Dermatol; 2010 Feb; 62(2):205-17. PubMed ID: 20115947
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hidradenitis suppurativa (acne inversa): early inflammatory events at terminal follicles and at interfollicular epidermis.
    von Laffert M; Helmbold P; Wohlrab J; Fiedler E; Stadie V; Marsch WC
    Exp Dermatol; 2010 Jun; 19(6):533-7. PubMed ID: 19659829
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa.
    Jemec GB; Wendelboe P
    J Am Acad Dermatol; 1998 Dec; 39(6):971-4. PubMed ID: 9843011
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Genetics of Hidradenitis Suppurativa.
    Ingram JR
    Dermatol Clin; 2016 Jan; 34(1):23-8. PubMed ID: 26617354
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hidradenitis suppurativa.
    Sabat R; Jemec GBE; Matusiak Ł; Kimball AB; Prens E; Wolk K
    Nat Rev Dis Primers; 2020 Mar; 6(1):18. PubMed ID: 32165620
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies.
    Revuz JE; Canoui-Poitrine F; Wolkenstein P; Viallette C; Gabison G; Pouget F; Poli F; Faye O; Roujeau JC; Bonnelye G; Grob JJ; Bastuji-Garin S
    J Am Acad Dermatol; 2008 Oct; 59(4):596-601. PubMed ID: 18674845
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular and functional changes in neutrophilic granulocytes induced by nicotine: a systematic review and critical evaluation.
    Brembach TC; Sabat R; Witte K; Schwerdtle T; Wolk K
    Front Immunol; 2023; 14():1281685. PubMed ID: 38077313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.